Interferon alpha and 13 cis retinoid acid in the therapy of metastatic renal cell carcinoma.

被引：0
|
作者：
Ostrizkova, L [1 ]
Kocak, I [1 ]
Palacova, M [1 ]
Kebedeova, D [1 ]
机构：
[1] Masaryk Mem Canc Inst, Brno, Czech Republic
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
359
引用
收藏
页码：81 / 81
页数：1
相关论文
共 50 条
  • [31] Use of STAT3 polymorphisms to predict overall survival in patients treated with interferon-alpha for metastatic renal cell carcinoma.
    Eto, Masatoshi
    Kamba, Tomomi
    Miyake, Hideaki
    Fujisawa, Masato
    Kamai, Takao
    Uemura, Hirotsugu
    Tsukamoto, Taiji
    Azuma, Haruhito
    Matsubara, Akio
    Nishimura, Kazuo
    Nakamura, Tsuyoshi
    Ogawa, Osamu
    Naito, Seiji
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [32] Association of resistance to antiangiogenic therapy with an immunosuppressive tumor microenvironment in metastatic renal cell carcinoma.
    Liu, Xiande
    Hoang, Anh
    Zhou, Lijun
    Kalra, Sarathi
    Yetil, Alper
    Sun, Mianen
    Ding, Zhiyong
    Tamboli, Pheroze
    Rao, Priya
    Karam, Jose A.
    Wood, Christopher G.
    Matin, Surena F.
    Zurita, Amado J.
    Bex, Axel
    Griffioen, Arjan W.
    Gao, Jianjun
    Sharma, Padmanee
    Tannir, Nizar M.
    Sircar, Kanishka
    Jonasch, Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [33] Interferon alpha (IFN) and 13 cia retinoic acid (cRA) in patients with advanced renal cell carcinoma (RCC)
    Jaremtchuk, AV
    Ponce, W
    Aman, EF
    Ferro, A
    ANNALS OF ONCOLOGY, 1998, 9 : 60 - 60
  • [34] Temsirolimus in Metastatic Chromophobe Renal Cell Carcinoma after Interferon and Sorafenib Therapy
    Paule, Bernard
    Brion, Nathalie
    ANTICANCER RESEARCH, 2011, 31 (01) : 331 - 333
  • [35] Neutrophil extracellular traps in relation to efficacy of systemic therapy for metastatic renal cell carcinoma.
    Shang, Bing-Qing
    Shi, Hongzhe
    Bi, Xin-Gang
    Song, Yan
    Qu, Wang
    Bai, Hongsong
    Wu, Jie
    Cui, Honglei
    Du, Gan
    Guo, Lei
    Zheng, Shan
    Ying, Jianming
    Li, Changling
    Ma, Jianhui
    Zhou, Ai-Ping
    Zhang, Shudong
    Shou, Jianzhong
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL)
  • [36] Metastatic renal cell carcinoma and capecitabine - salvage therapy after treatment with interferon
    Salma, Svetlana Z.
    Trifunovic, Jasna D.
    Nikolin, Borislava L.
    ANNALS OF ONCOLOGY, 2004, 15 : 120 - 120
  • [37] Interferon alfa therapy against metastatic iris tumor of renal cell carcinoma
    Ikeda, T
    Sato, K
    Tokuyama, T
    ARCHIVES OF OPHTHALMOLOGY, 2000, 118 (06) : 846 - 847
  • [38] Combination therapy with nivolumab and tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma.
    Garmezy, Benjamin
    Zhang, Tian
    Laccetti, Andrew Leonard
    Economides, Minas P.
    Shah, Amishi Yogesh
    Tannir, Nizar M.
    Jonasch, Eric
    Msaouel, Pavlos
    Zurita, Amado J.
    Corn, Paul Gettys
    Venkatesan, Aradhana M.
    Brown, Landon Carter
    Kao, Chester
    Kinsey, Emily Noelle
    Harrison, Michael Roger
    Armstrong, Andrew J.
    George, Daniel J.
    Campbell, Matthew T.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [39] Systemic therapy in patients with metastatic Xp11.2 translocation renal cell carcinoma.
    Yan, Xieqiao
    Li, Siming
    Chi, Zhihong
    Si, Lu
    Cui, Chuanliang
    Kong, Yan
    Zhou, Li
    Tang, Bixia
    Wu, Xiaowen
    Mao, Lili
    Wang, Xuan
    Lian, Bin
    Bai, Xue
    Dai, Jie
    Guo, Jun
    Sheng, Xinan
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [40] Systemic therapy of metastatic renal cell carcinoma. From many options to the therapeutic strategy
    Ringhoffer, M.
    Rinnab, L.
    Kuefer, R.
    Greiner, J.
    UROLOGE, 2009, 48 (11): : 1308 - 1317
12345